Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Directors Deals Ltd.
$12.00
Provider: MarketLine (a Datamonitor Company)
$50.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gimv Nv Sells Stake in Ablynx NV


Thursday, 17 Oct 2013 11:45am EDT 

Gimv Nv announced that the Company and its subsidiary Biotech Fonds Vlaanderen sold their remaining stake in the Belgian biotech company Ablynx NV. This exit has a positive impact of EUR 3.8 million (0.15 EUR per share) on Gimv NV's last published equity value as per 30 June 2013. 

Company Quote

37.33
-0.035 -0.09%
7:39am EST